Shopping Cart
Remove All
Your shopping cart is currently empty
ZLWT-37 is a potent, orally active inhibitor of CDKs, specifically targeting CDK9 (IC50: 0.002 μM) and CDK2 (IC50: 0.054 μM), and is capable of blocking the cell cycle of HCT116 cells in G2/M phase and inducing apoptosis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $1,980 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $2,500 | 10-14 weeks | 10-14 weeks |
| Description | ZLWT-37 is a potent, orally active inhibitor of CDKs, specifically targeting CDK9 (IC50: 0.002 μM) and CDK2 (IC50: 0.054 μM), and is capable of blocking the cell cycle of HCT116 cells in G2/M phase and inducing apoptosis. |
| Targets&IC50 | CDK2:0.054 μM, CDK9:0.002 μM |
| Molecular Weight | 464 |
| Formula | C26H30ClN5O |
| Smiles | #N/A |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.